Accepted for Publication: December 27, 2022.
Published Online: February 22, 2023. doi:10.1001/jamadermatol.2022.6266
Corresponding Author: Helen Bui, MD, UNC Hospitals, 101 Manning Drive, Chapel Hill, NC 27514 (helen.bui@unchealth.unc.edu).
Author Contributions: Drs Bui and Sayed had full access to all of the data in the study and take responsibility for the integrity of the data and the accuracy of the data analysis.
Concept and design: Bui, Bechara, George, Goldberg, Saylor, Sayed.
Acquisition, analysis, or interpretation of data: Bui, Bechara, George, Goldberg, Hamzavi, Kirby, Sayed.
Drafting of the manuscript: Bui, Bechara, Hamzavi, Saylor, Sayed.
Critical revision of the manuscript for important intellectual content: Bui, Bechara, George, Goldberg, Hamzavi, Kirby, Sayed.
Statistical analysis: Bui.
Administrative, technical, or material support: Bui, Bechara, Goldberg, Hamzavi, Sayed.
Supervision: Bechara, Goldberg, Kirby, Sayed.
Conflict of Interest Disclosures: Dr George reported personal fees from AbbVie unrelated to topic outside the submitted work. Dr Hamzavi reported personal fees from Incyte, Abbvie, grants from Pfizer, personal fees from UCB, Jansen, Boerhinger Ingelheim, Novartis, and nonfinancial support from Lenicura during the conduct of the study. Dr Kirby reported personal fees from AbbVie, ChemoCentryx, grants from Incyte, personal fees from Janssen, Novartis, and UCB outside the submitted work. Dr Sayed reported grants from AbbVie Education grant, investigator fees to institution, personal fees from AbbVie speaking, consulting, personal fees from Novartis Speaking, consulting, grants from Novartis Investigator fees paid to institution, grants from UCB Investigator fees paid to institution, personal fees from UCB Consulting fees, grants from Incyte Investigational fees paid to institution, grants from Chemocentryx Investigator fees paid to institution, grants from InflaRx Investigator fees paid to institution, personal fees from InflaRx Consulting, and personal fees from Amaris Consulting outside the submitted work; and I am a directing member of the HS Foundation. No other disclosures were reported.
Funding/Support: National Institute of Health, National Institute of Arthritis, Musculoskeletal, and Skin Diseases grant number 1R21AR075996-01A1. We thank the National Institute of Health, National Institute of Arthritis, Musculoskeletal, and Skin Diseases grant number 1R21AR075996-01A1 for supporting the design and conduct of the study; collection, management, analysis, and interpretation of the data.
Role of the Funder/Sponsor: The National Institute of Health and the National Institute of Arthritis, Musculoskeletal, and Skin Diseases had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication.